{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:52:33Z","timestamp":1791179553411,"version":"4.1.0"},"reference-count":29,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Constitutive expression of the inflammatory cytokine tumor necrosis factor-\u03b1 (TNF-\u03b1) is characteristic of malignant ovarian surface epithelium. We investigated the hypothesis that this autocrine action of TNF-\u03b1 generates and sustains a network of other mediators that promote peritoneal cancer growth and spread. When compared with two ovarian cancer cell lines that did not make TNF-\u03b1, constitutive production of TNF-\u03b1 was associated with greater release of the chemokines CCL2 and CXCL12, the cytokines interleukin-6 (IL-6) and macrophage migration-inhibitory factor (MIF), and the angiogenic factor vascular endothelial growth factor (VEGF). TNF-\u03b1 production was associated also with increased peritoneal dissemination when the ovarian cancer cells were xenografted. We next used RNA interference to generate stable knockdown of TNF-\u03b1 in ovarian cancer cells. Production of CCL2, CXCL12, VEGF, IL-6, and MIF was decreased significantly in these cells compared with wild-type or mock-transfected cells, but in vitro growth rates were unaltered. Tumor growth and dissemination in vivo were significantly reduced when stable knockdown of TNF-\u03b1 was achieved. Tumors derived from TNF-\u03b1 knockdown cells were noninvasive and well circumscribed and showed high levels of apoptosis, even in the smallest deposits. This was reflected in reduced vascularization of TNF-\u03b1 knockdown tumors. Furthermore, culture supernatants from such cells failed to stimulate endothelial cell growth in vitro. We conclude that autocrine production of TNF-\u03b1 by ovarian cancer cells stimulates a constitutive network of other cytokines, angiogenic factors, and chemokines that may act in an autocrine\/paracrine manner to promote colonization of the peritoneum and neovascularization of developing tumor deposits. [Cancer Res 2007;67(2):585\u201392]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-2941","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T11:53:23Z","timestamp":1169121203000},"page":"585-592","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":341,"title":["The Inflammatory Cytokine Tumor Necrosis Factor-\u03b1 Generates an Autocrine Tumor-Promoting Network in Epithelial Ovarian Cancer Cells"],"prefix":"10.1158","volume":"67","author":[{"given":"Hagen","family":"Kulbe","sequence":"first","affiliation":[{"name":"1Centre for Translational Oncology, Institute of Cancer and the Cancer Research-UK Clinical Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Thompson","sequence":"additional","affiliation":[{"name":"1Centre for Translational Oncology, Institute of Cancer and the Cancer Research-UK Clinical Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L.","family":"Wilson","sequence":"additional","affiliation":[{"name":"1Centre for Translational Oncology, Institute of Cancer and the Cancer Research-UK Clinical Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Robinson","sequence":"additional","affiliation":[{"name":"1Centre for Translational Oncology, Institute of Cancer and the Cancer Research-UK Clinical Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Hagemann","sequence":"additional","affiliation":[{"name":"1Centre for Translational Oncology, Institute of Cancer and the Cancer Research-UK Clinical Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rewas","family":"Fatah","sequence":"additional","affiliation":[{"name":"2Bone and Joint Research Unit, William Harvey Research Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, London, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gould","sequence":"additional","affiliation":[{"name":"2Bone and Joint Research Unit, William Harvey Research Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, London, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Ayhan","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Balkwill","sequence":"additional","affiliation":[{"name":"1Centre for Translational Oncology, Institute of Cancer and the Cancer Research-UK Clinical Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,1,18]]},"reference":[{"key":"2022061623355300300_B1","doi-asserted-by":"crossref","unstructured":"Moore R, Owens D, Stamp G, et al. Tumour necrosis factor-\u03b1 deficient mice are resistant to skin carcinogenesis. Nat Med\u20081999; 5: 828\u201331.","DOI":"10.1038\/10552"},{"key":"2022061623355300300_B2","doi-asserted-by":"crossref","unstructured":"Arnott CH, Scott KA, Moore RJ, et al. Tumour necrosis factor-\u03b1 mediates tumour promotion via a PKC\u03b1- AP-1-dependent pathway. Oncogene\u20082002; 21: 4728\u201338.","DOI":"10.1038\/sj.onc.1205588"},{"key":"2022061623355300300_B3","doi-asserted-by":"crossref","unstructured":"Pikarsky E, Porat RM, Stein I, et al. NF-\u03baB functions as a tumour promoter in inflammation-associated cancer. Nature\u20082004; 431: 4461\u20136.","DOI":"10.1038\/nature02924"},{"key":"2022061623355300300_B4","doi-asserted-by":"crossref","unstructured":"Szlosarek PW, Grimshaw MJ, Kulbe H, et al. Expression and regulation of tumor necrosis factor-\u03b1 in normal and malignant ovarian epithelium. Mol Cancer Ther\u20082006; 5: 382\u201390.","DOI":"10.1158\/1535-7163.MCT-05-0303"},{"key":"2022061623355300300_B5","doi-asserted-by":"crossref","unstructured":"Szlosarek P, Balkwill F. Tumour necrosis factor-\u03b1: a potential target in the therapy of solid tumors. Lancet Oncol\u20082003; 4: 565\u201373.","DOI":"10.1016\/S1470-2045(03)01196-3"},{"key":"2022061623355300300_B6","doi-asserted-by":"crossref","unstructured":"Naylor MS, Stamp GWH, Foulkes WD, et al. Tumor necrosis factor and its receptors in human ovarian cancer. J Clin Invest\u20081993; 91: 2194\u2013206.","DOI":"10.1172\/JCI116446"},{"key":"2022061623355300300_B7","doi-asserted-by":"crossref","unstructured":"Szlosarek P, Charles KA, Balkwill FR. Tumour necrosis factor-\u03b1 as a tumour promoter. Eur J Cancer\u20082006; 42: 745\u201350.","DOI":"10.1016\/j.ejca.2006.01.012"},{"key":"2022061623355300300_B8","doi-asserted-by":"crossref","unstructured":"Kulbe H, Hagermann T, Szlosarek PW, et al. The inflammatory cytokine TNF-\u03b1 upregulates chemokine receptor expression on ovarian cancer cells. Cancer Res\u20082005; 65: 10355\u201362.","DOI":"10.1158\/0008-5472.CAN-05-0957"},{"key":"2022061623355300300_B9","doi-asserted-by":"crossref","unstructured":"Malik STA, Griffin DB, Fiers W, et al. Paradoxical, effects of tumour necrosis factor in experimental ovarian cancer. Int J Cancer\u20081989; 44: 918\u201325.","DOI":"10.1002\/ijc.2910440529"},{"key":"2022061623355300300_B10","doi-asserted-by":"crossref","unstructured":"Madhusudan S, Muthuramalingam SR, Braybrooke JP, et al. A phase II study of ethanercept (ENBREL) a tumour necrosis factor-\u03b1 inhibitor in recurrent ovarian cancer. J Clin Oncol\u20082005; 10: 6528\u201334.","DOI":"10.1158\/1078-0432.CCR-04-0730"},{"key":"2022061623355300300_B11","unstructured":"Benard J, Da Silva J, De Blois MC, et al. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res\u20081985; 45: 4970\u20139."},{"key":"2022061623355300300_B12","doi-asserted-by":"crossref","unstructured":"Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science\u20082002; 296: 550\u20133.","DOI":"10.1126\/science.1068999"},{"key":"2022061623355300300_B13","doi-asserted-by":"crossref","unstructured":"Reynolds AR, Reynolds LE, Nagel TE, et al. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in \u03b23-integrin-deficient mice. Cancer Res\u20082004; 64: 8643\u201350.","DOI":"10.1158\/0008-5472.CAN-04-2760"},{"key":"2022061623355300300_B14","doi-asserted-by":"crossref","unstructured":"Negus RPM, Stamp GWH, Relf MG, et al. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest\u20081995; 95: 2391\u20136.","DOI":"10.1172\/JCI117933"},{"key":"2022061623355300300_B15","doi-asserted-by":"crossref","unstructured":"Scotton C, Milliken D, Wilson J, et al. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br J Cancer\u20082001; 85: 891\u20137.","DOI":"10.1054\/bjoc.2001.2020"},{"key":"2022061623355300300_B16","doi-asserted-by":"crossref","unstructured":"Rudlowski C, Pickart AK, Fuhljahn C, et al. Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Int J Gynecol Cancer\u20082006; 16: 183\u20139.","DOI":"10.1136\/ijgc-00009577-200602001-00029"},{"key":"2022061623355300300_B17","doi-asserted-by":"crossref","unstructured":"Kryczek I, Grybos M, Karabon L, et al. IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity. Br J Cancer\u20082000; 82: 621\u20138.","DOI":"10.1054\/bjoc.1999.0973"},{"key":"2022061623355300300_B18","doi-asserted-by":"crossref","unstructured":"Hagemann T, Wilson J, Kulbe H, et al. TNF-\u03b1 dependent increased c-Jun and NF-\u03baB activity in tumour cell lines upon co-cultivation with macrophages. J Immunol\u20082005; 175: 1197\u2013205.","DOI":"10.4049\/jimmunol.175.2.1197"},{"key":"2022061623355300300_B19","doi-asserted-by":"crossref","unstructured":"Whitworth MK, Backen AC, Clamp AR, et al. Regulation of fibroblast growth factor_2 activity by human ovarian cancer tumor endothelium. Clin Cancer Res\u20082005; 11: 4282\u20138.","DOI":"10.1158\/1078-0432.CCR-04-1386"},{"key":"2022061623355300300_B20","doi-asserted-by":"crossref","unstructured":"Jin DK, Shido K, Kopp H-G, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med\u20082006; 12: 557\u201367.","DOI":"10.1038\/nm1400"},{"key":"2022061623355300300_B21","doi-asserted-by":"crossref","unstructured":"Galban S, Fan J, Martindale JL, et al. von Hippel-Lindau protein-mediated repression of tumor necrosis factor \u03b1 translation revealed through use of cDNA arrays. Mol Cell Biol\u20082003; 23: 2316\u201328.","DOI":"10.1128\/MCB.23.7.2316-2328.2003"},{"key":"2022061623355300300_B22","doi-asserted-by":"crossref","unstructured":"Janes KA, Gaudet S, Albeck JG, et al. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell\u20082006; 124: 1225\u201339.","DOI":"10.1016\/j.cell.2006.01.041"},{"key":"2022061623355300300_B23","doi-asserted-by":"crossref","unstructured":"Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature\u20082005; 438: 820\u20137.","DOI":"10.1038\/nature04186"},{"key":"2022061623355300300_B24","doi-asserted-by":"crossref","unstructured":"Kryczek I, Lange A, Mottram P, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res\u20082005; 65: 465\u201372.","DOI":"10.1158\/0008-5472.465.65.2"},{"key":"2022061623355300300_B25","doi-asserted-by":"crossref","unstructured":"Mantovani A, Allavena P, Sica A. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer\u20082004; 40: 1660\u20137.","DOI":"10.1016\/j.ejca.2004.03.016"},{"key":"2022061623355300300_B26","doi-asserted-by":"crossref","unstructured":"Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell\u20082006; 124: 263\u20136.","DOI":"10.1016\/j.cell.2006.01.007"},{"key":"2022061623355300300_B27","doi-asserted-by":"crossref","unstructured":"Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol\u20082003; 3: 791\u2013800.","DOI":"10.1038\/nri1200"},{"key":"2022061623355300300_B28","doi-asserted-by":"crossref","unstructured":"Syed V, Ulinski G, Mok SC, et al. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst\u20082002; 94: 617\u201329.","DOI":"10.1093\/jnci\/94.8.617"},{"key":"2022061623355300300_B29","doi-asserted-by":"crossref","unstructured":"Yan L, Anderson GM, DeWitte M, et al. Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur J Cancer\u20082006; 42: 793\u2013802.","DOI":"10.1016\/j.ejca.2006.01.013"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/2\/585\/2866629\/585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/2\/585\/2866629\/585.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:14:17Z","timestamp":1655424857000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/2\/585\/533502\/The-Inflammatory-Cytokine-Tumor-Necrosis-Factor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,15]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,1,18]]},"published-print":{"date-parts":[[2007,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-2941","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,15]]}}}